Women pursuing IVF after 35 are often presented with a menu of optional add-on procedures, ranging from endometrial scratching to assisted hatching and additional embryo screening. These add-ons are frequently marketed as ways to improve success rates, but the evidence supporting many of them is mixed, and understanding what current research actually shows can help women have more informed conversations with their care teams alongside decisions around overall IVF cost and budgeting.
This article reviews some commonly offered add-ons, what research suggests about their effectiveness, and questions that may be worth raising with a fertility clinic before agreeing to additional procedures.
It can also be worth asking a prospective clinic directly about their overall philosophy toward add-ons: some clinics take a conservative approach, recommending only interventions with strong supporting evidence, while others offer a broader menu and let patients choose. Neither approach is inherently better, but understanding a clinic’s general philosophy before treatment begins can help set expectations for how often add-ons might come up in your specific care plan.
What Research Reviews Have Found
Systematic reviews of IVF add-ons, including analyses referenced by the National Institutes of Health, have generally found that many commonly offered extra procedures lack strong evidence of improving live birth rates, even though they may be marketed with confidence. Some professional bodies have called for greater transparency from clinics about the evidence quality behind specific add-ons before patients are asked to pay for them.
Commonly Offered Add-Ons and What Evidence Suggests
Endometrial Scratching
This procedure, intended to encourage embryo implantation, was popular for a period but larger randomized trials have generally not shown a consistent benefit for most patients, according to several reviewed studies.
Assisted Hatching
This technique involves thinning or opening part of the embryo’s outer layer before transfer. Evidence for a meaningful benefit in unselected patients remains limited, though it may be considered in specific circumstances at a physician’s discretion.
Preimplantation Genetic Testing
Genetic screening of embryos before transfer is more established for certain situations, such as known genetic conditions or recurrent loss, though its value for routine use in all patients over 35 continues to be studied and debated among specialists.
Weighing Cost Against Uncertain Benefit
Add-on procedures often carry additional fees not covered by insurance, and evaluating whether a specific add-on is appropriate may involve weighing the additional cost against uncertain or modest potential benefit for your individual situation. Some clinics provide written summaries of the evidence for each add-on, which can be a useful starting point for a more detailed conversation with your physician.
Questions to Ask Before Agreeing to an Add-On
Clinicians who specialize in reproductive medicine often suggest asking specifically what evidence supports a proposed add-on for patients with a similar profile, what the additional cost is, and whether the clinic’s success statistics account for how frequently add-ons are used. These questions can help clarify whether a recommendation is tailored to individual circumstances or offered more routinely.
How to Read Clinic Success Rate Statistics
Fertility clinics often advertise success rates prominently, but these figures can be presented in different ways that make direct comparisons difficult. Some clinics report success per embryo transfer, others per completed cycle, and others per patient across multiple cycles, and each method can produce a meaningfully different number even for clinics with similar actual outcomes. Age-specific breakdowns are particularly important to review, since a clinic’s overall success rate may reflect a younger patient population rather than outcomes specific to women over 35.
The Society for Assisted Reproductive Technology collects and publishes standardized clinic-level data in the United States, which can offer a more consistent basis for comparison than a clinic’s own marketing materials alone. When add-ons are being recommended, it can also be useful to ask whether the clinic’s published success statistics were achieved with or without routine use of the specific add-on being suggested to you, since this context can meaningfully change how you interpret the recommendation.
The Placebo Effect and Patient Experience With Add-Ons
Some researchers and clinicians have noted that add-on procedures may provide a psychological benefit even when the physiological evidence is limited, since feeling proactive during a stressful process can reduce anxiety for some patients. This is not a reason to pursue an add-on that carries meaningful cost or risk without benefit, but it is a factor some patients weigh when the add-on in question is low-risk and low-cost, even if the evidence for physiological benefit remains uncertain.
Clinics have an ethical responsibility to be clear about this distinction, differentiating between a procedure that carries a plausible biological rationale backed by some evidence and one offered primarily because patients request it. Asking your physician directly to characterize a recommended add-on in these terms can help clarify whether you are making a decision based on physiological evidence, personal comfort, or some combination of both.
Frequently Asked Questions
Are IVF add-ons ever worth considering after 35?
Some add-ons may be appropriate in specific clinical situations, such as a history of failed implantation or known genetic risk, though evidence for routine use in all patients remains limited. This is a decision best made individually with your care team.
Why do clinics offer add-ons if the evidence is limited?
Reasons vary, and may include patient demand, differing interpretations of emerging research, or a clinic’s specific patient population. Asking directly about the evidence base for your situation can help clarify the reasoning.
Does declining an add-on lower my chances of success?
For many add-ons with limited evidence, research suggests outcomes are similar with or without them for most patients, though individual circumstances can differ and this is worth discussing with your physician.
Documenting Your Own Questions Over Time
Because IVF involves multiple appointments and a great deal of information delivered over a short period, some patients find it helpful to keep a running list of questions as they arise, rather than trying to remember everything for a single consultation. This can be particularly useful when new add-ons are suggested partway through a treatment plan, since it gives you a structured way to revisit the evidence and cost considerations before agreeing to anything additional.
How can I find a fertility clinic that takes a conservative approach to add-ons?
Asking directly during an initial consultation about a clinic’s general philosophy toward add-on procedures, and requesting to see their published success rates broken down by age group, can help you gauge whether a clinic’s approach aligns with your own preferences before committing to treatment there.
Key Takeaways
- Many IVF add-ons lack strong evidence of improving live birth rates for the average patient.
- Some add-ons may have a role in specific clinical circumstances rather than routine use.
- Cost and evidence quality are both worth weighing before agreeing to additional procedures.
- Asking your clinic directly about evidence specific to your situation can support a more informed decision.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.